SomnoMed Limited
Research SomnoMed Limited (RJV) on Bullrun: market cap EUR 70.41M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRJV
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 70.41M
- Financial periodFY2024
- RevenueEUR 91.65M
- Revenue growth9.6%
- Net income-EUR 12.24M
- Free cash flow-EUR 11.67M
- Gross margin60.2%
Valuation Snapshot
latest market cap is EUR 70.41M.
About SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position;
Frequently asked questions
What is SomnoMed Limited's market cap?
SomnoMed Limited's market capitalization is EUR 70.41M.
What does SomnoMed Limited do?
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.